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Adrenocortical oncocytomas are very rare, with only 47 cases reported in the English literature. They are
usually benign and nonfunctional. Herein, we report on a 30-year-old female patient presenting with
extreme weight gain (17 kg in a year), moon face, buffalo hump, central obesity and edema in both legs.
Computed tomography revealed a 3.2 cm solid left adrenal tumor. A clipless laparoscopic adrenalectomy
was performed. Pathology revealed an adrenocortical oncocytoma.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.1. Introduction
Oncocytomas are neoplasms comprised of cells replete with
eosinophilic granular cytoplasm packed with swollen mitochon-
dria. They can arise in the kidney, thyroid, salivary glands, para-
thyroid, lung, pituitary gland and ovaries.1,2 The term “oncocyte”
was ﬁrst used by Hamperl in 1950 to describe large, highly eosin-
ophilic granular cells associated with a Hurthle cell tumor of the
thyroid gland.3 Adrenocortical oncocytomas are very rare, with
only 47 cases reported in the English literature.4 They are usually
benign and nonfunctional. Only seven cases of functional adrenal
oncocytoma have been reported.5 Herein, we report on a rare case
of functional adrenal oncocytoma in a patient presenting with
Cushing’s syndrome.
2. Case report
A 30-year-old female patient presented with extreme weight
gain (17 kg in 1 year) and bilateral leg edema for 3 months. She had
a history of essential hypertension since 2008 and obesity. The
family history was noncontributory. She had complained of prox-
imal muscle weakness and thigh soreness for a year and of getting
fatter, especially in the face. In the past 3 months, she hadackay Memorial Hospital, 92
n.
in).
ciation. Published by Elsevier Taiwexperienced palpitations, insomnia, anxiety and persistent swelling
in her lower legs. She had irregular menstrual cycles with menor-
rhagia. Her body weight increased from 71 to 79 kg in 20 days. A
physical examination revealed a moon face, buffalo hump, central
obesity and edema in both legs.
Blood tests showed that cortisol (morning, afternoon and dexa-
methasone suppression test), aldosterone (standing and lying
down), adenocorticotropic hormone, thyroid-stimulating hormone,
luteinizing hormone, follicle-stimulating hormone and prolactin
levelswere all within normal ranges. Her testosterone level (1.43 ng/
mL) was high. Her dehydroepiandrosterone (121.0 mg/dL) and free
T4 (0.64 ng/dL) levels were low. Urine cortisol (638.40 mg/day), 17-
ketosteroids (27.6 mg/day) and 17-OH progesterone (43.2 mg/day)
levels were high.
Adrenal computed tomography (CT) revealed a 3.2 cm well-
deﬁned, nearly homogeneously solid mass with a mean Houns-
ﬁeld unit (HU) number of around 30 on precontrast scans, favoring
a relatively lipid-poor adenoma (Fig. 1). An Adrenal scans with
Radioiodine - Labeled Norcholesterol (NP-59) showed unilateral
visualization of the left adrenal gland, and a left adrenal adenoma
was diagnosed.
Due to the presenting symptoms and signs and the high urine
cortisol level, the impression was of a functional adrenal adenoma
with Cushing’s syndrome, and a clipless left laparoscopic adrenal-
ectomy was performed via a retroperitoneal approach. On gross
examination, the specimen was 3.5 cm  2.5 cm  2.0 cm and
weighed 16.5 g. Microscopically, the tumor was composed of
trabecular and solidly arranged oncocytic cells with mild nuclearan LLC. Open access under CC BY-NC-ND license.
Fig. 1. Adrenal CT revealing a well-deﬁned 3.2 cm, nearly homogeneously solid mass
(arrow) with a mean HU number of around 30 on precontrast scans (A) and around 55
on 10-min postcontrast images (>70% washout) (B), favoring a relatively lipid-poor
adenoma.
Fig. 2. (A) Microscopically, tumor cells are abundantly eosinophilic with granular
cytoplasm and are arranged in a nested pattern (hematoxylin and eosin stain 200x);
and (B) tumor cells were diffusely strongly positive for cytoplasmic alpha-inhibin
indicating adrenal cortical differentiation (alpha-inhibin 100x).
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Extramedullary hematopoiesis was seen within the tumor and in
the periadrenal soft tissue. Immunohistochemical staining showed
that the tumor was strongly positive for alpha-inhibin and negative
for cytokeratin (AE1/AE3), vimentin, chromogranin A, epithelial
membrane antigen and HepPar1 antigen. The Ki-67 index was very
low. Pathological impressions were a left adrenal oncocytoma and
extramedullary hematopoiesis (Fig. 2A and B).
The patient’s postoperative recovery was uneventful. Intrave-
nous hydrocortisone sodium succinate was given postoperatively,
and on the second postoperative day the patient was switched to
oral cortisone acetate. The patient had lost 4 kg of weight by the
30th postoperative day.3. Discussion
Adrenal masses are usually silent and are incidentally detected
in 12% of abdominal CT scans.6 These adrenal incidentalomas may
be cortical adenomas, myelolipomas, pheochromocytomas, cysts,
ganglioneuromas, adrenocortical carcinomas or adrenal metas-
tases, with nonfunctioning cortical adenomas being the most
common.7 In order to distinguish nonfunctional from functional
adrenal masses, a biochemical evaluation should be performed.
Surgical removal is indicated for adrenal masses that are functional
or >6 cm in size.
Adrenal oncocytomas are very rare, and only 48 cases have
been reported to date.4 Many such tumors are benign and
nonfunctional, and are detected incidentally. Adrenal oncocyto-
mas are reported to be more common on the left-hand side (2:1),
with tumor size ranging from 3 cm to 15 cm (median 8 cm) and
weighing from 30 g to 865 g (mean 281 g). The mean age of
diagnosis is 46 years and the condition is prevalent in females.
Only two cases of a malignant adrenal oncocytoma have been re-
ported: one was an adrenal oncocytoma with local invasion and
distant metastases8 and the other was a 51-year-old male with
a 15.0 cm  16.0 cm  17.2 cm adrenal mass. In the latter case, the
man had enlarged periarterial lymph nodes, elevated serum
Table 1
Criteria of malignant oncocytoma proposed by Bisceglia et al.13
Major criteria Minor criteria
Mitotic rate >5 mitoses/50
high power ﬁelds
Large tumor size: >10 cm and/or >200 g
Atypical mitosis Necrosis
Venous invasion Capsular invasion; sinusoidal invasion
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an overnight 1-mg dexamethasone test and increased urinary
excretion of 17-hydroxycorticosteroids. The mass was unresect-
able due to tumor invasion of the inferior vena cava.9
Tahar et al have reported that the clinical symptoms of func-
tional adrenocortical oncocytomas include virilization in three
female cases, Cushing’s syndrome in a male case, bilateral
gynecomastia in two male cases and pseudopuberty in a female
child.5 A MEDLINE search revealed that only one case of Cushing’s
syndrome10 and two cases of subclinical Cushing’s syndrome have
been reported.9,11 Our case is the second adrenocortical oncocy-
toma presenting with Cushing’s syndrome. In our case, the patient
had irregular menstrual cycles with menorrhagia, moon face,
buffalo hump, central obesity and edema in both legs. Cortisol
levels (morning, afternoon and on the dexamethasone suppression
test) were normal, but urine cortisol (638.4 mg/day; reference
range, 20.090.0 mg/day) was high. According to Harrision’s Prin-
ciples of Internal Medicine,12 in difﬁcult cases, such as obese or
depressed patients, 24-h urine free cortisol can be measured, and
a level of >140 nmol/day (50 mg/day) is suggestive of Cushing’s
syndrome.
A diagnosis of an oncocytoma is based on histological and
immunohistochemical studies. Oncocytomas are neoplasms made
up of cells with large amounts of eosinophilic granular cytoplasm
ﬁlled with swollen mitochondria.2 In immunohistochemical
studies, vimentin and keratin are frequently identiﬁed, and the
tumors are strongly positive for antimitochondrial antibodies.13 In
the present case, the tumor was composed of trabecular and solidly
arranged oncocytic cells, with mild nuclear atypia and no mitotic
activity. The tumor was strongly positive for alpha-inhibin and
negative for cytokeratin (AE1/AE3), vimentin, chromogranin A,
epithelial membrane antigen and HepPar1.
Bisceglia et al14 have produced newcriteria for the differentiation
of benign from malignant adrenocortical oncocytomas (Table 1).
If a tumor meets one or more major criteria, it is deﬁned as malig-
nant. If the tumor meets one or more minor criteria, it is considered
borderline malignant. If no major or minor criteria are met,
the oncocytoma is benign. Immunohistochemical and molecularproﬁles can be used to determine the tumor’s nature and predict its
behavior. The presence of Ki-67(þ), p21(þ), p27(þ) and Mdm-2(-)
can be used to predict malignancy and distant spread of adrenal
cortical tumors. The sensitivity of these proteins is low, however,
and only 13% of adrenal cortical carcinomas expressed this pheno-
type.15 In the present case, the tumor was functional, 3.5 cm in size,
the Ki-67 proliferative index was very low, and no major or minor
criteria were met.
4. Conclusion
In patients presenting with symptoms and signs of Cushing’s
syndrome, 24-h urine cortisol is a valuable test for the diagnosis of
Cushing’s syndrome if plasma cortisol levels are normal. Adreno-
cortical oncocytomas are rare and usually benign and nonfunc-
tional. A functional adrenal oncocytoma may, however, present as
Cushing’s syndrome. This must therefore be taken into consider-
ation in differential diagnosis.
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